In focus · trending topic

genetherapy

42 stories · following the connections

Abeona Therapeutics Announces Upcoming Presentations

By Nasdaq OMXMay 8, 2018, 12:15 PM UTC

Abeona Announces FDA Grants RMAT Designation to ABO-102 Gene Therapy in MPS IIIA

By Nasdaq OMXApr 23, 2018, 12:15 PM UTC

Abeona Therapeutics Appoints Carsten Thiel, Ph.D., as Chief Executive Officer

By Nasdaq OMXApr 2, 2018, 12:15 PM UTC

Abeona Therapeutics Reports Fourth Quarter 2017 Financial Results and Business Highlights

By Nasdaq OMXMar 16, 2018, 9:10 PM UTC

Abeona Therapeutics Receives FDA Rare Pediatric Disease Designation for ABO-202 Gene Therapy Program in CLN1 Disease

By Nasdaq OMXMar 15, 2018, 12:45 PM UTC

Abeona Therapeutics Announces Upcoming Conference Participation

By Nasdaq OMXFeb 21, 2018, 1:45 PM UTC

Abeona Therapeutics Reports Top-Line Data from Phase 1/2 Gene Therapy Trial in MPS IIIA

By Nasdaq OMXFeb 8, 2018, 7:00 PM UTC

Abeona Receives FDA Regenerative Medicine Advanced Therapy Designation for EB-101 Gene Therapy in Epidermolysis Bullosa

By Nasdaq OMXJan 29, 2018, 1:45 PM UTC